Quick Take-Home Message:
DILI can be intrinsic (predictable) or idiosyncratic (unpredictable), with a broad spectrum of presentations from mild enzyme elevations to acute liver failure. Early recognition, monitoring, and drug cessation are key.
Feature
Intrinsic (Dose-Dependent)
Idiosyncratic (Dose-Independent)
Predictability
Predictable, dose-related
Unpredictable, not dose-related
Example Drugs
Acetaminophen
Amoxicillin-clavulanate, Isoniazid, Minocycline
Pathogenesis
Overload of toxic metabolites
Immune-mediated or metabolic idiosyncrasy
Onset
Hours to days
Weeks to months
Feature
Hepatocellular
Cholestatic
Mixed
Lab Findings
High ALT, mild ALP
High ALP, mild ALT
Both ALT and ALP elevated
Example Drugs
Acetaminophen, Isoniazid
Chlorpromazine, Erythromycin
Amoxicillin-clavulanate, Carbamazepine
Drug
Type
Risk Window
Time-to-Onset
Acetaminophen
Intrinsic
Short (hours-days)
24-48 hours
Amoxicillin-clavulanate
Idiosyncratic
Weeks
1-6 weeks
Isoniazid
Idiosyncratic
Months
1-6 months
Methotrexate
Idiosyncratic
Months-Years
Months to Years
Method
Key Features
Example Use
RUCAM
Structured scoring, time relationships, exclusion of other causes
Amoxicillin-clavulanate DILI assessment
Clinical Judgment
Considers history, drug profiles, alternative causes
Suspected Ketoconazole hepatotoxicity
ALDILI
Considers drug levels, ingredients, alternative causes